MCOD methods reveal substantial underestimation of diabetes- and cardiovascular-related mortality compared to underlying cause of death data, with MCOD-DM mortality exceeding UCOD by up to 70% in Brazil and Colombia during the COVID-19 pandemic.
Key Findings
Results
Multiple cause of death (MCOD) analysis revealed that diabetes mellitus mortality was underestimated by up to 70% when using only underlying cause of death (UCOD) data.
Data covered death certificates from Brazil (n = 6,207,785) and Colombia (n = 1,180,880) from 2019 through 2022
MCOD-DM mortality exceeded UCOD estimates by up to 70%
This discrepancy was observed across both Latin American countries studied
The finding held across the pandemic period (2019–2022)
Results
In Colombia, MCOD-derived cardiovascular disease (CVD) mortality surpassed UCOD estimates during 2020–2021, corresponding to approximately 1,950 extra male and 1,560 extra female CVD deaths in 2021.
The excess CVD deaths identified through MCOD were specific to the COVID-19 pandemic years 2020–2021
Approximately 1,950 extra male CVD deaths were identified in Colombia in 2021 using MCOD versus UCOD
Approximately 1,560 extra female CVD deaths were identified in Colombia in 2021 using MCOD versus UCOD
This pattern suggests COVID-19 contributed to CVD deaths that were not captured as CVD in the underlying cause
Results
Discrepancies between MCOD and UCOD estimates for neoplasms and non-COVID communicable diseases were smaller and stable across the study period.
Neoplasm mortality rate differences between MCOD and UCOD were relatively small compared to diabetes and CVD
Non-COVID communicable disease discrepancies were also smaller and did not show pandemic-related shifts
The stability of these discrepancies contrasts with the pandemic-period amplification seen for DM and CVD
This pattern suggests COVID-19 specifically exacerbated the underestimation of metabolic and cardiovascular mortality
Methods
The study used a weighted MCOD methodology assigning 50% weight to the underlying cause of death and distributing the remaining 50% equally among contributing causes.
All death certificates for residents of Brazil and Colombia from 2019 through 2022 were included
Brazil contributed n = 6,207,785 death certificates and Colombia contributed n = 1,180,880
Weights were assigned as 50% to UCOD and the remainder equally among contributing causes
Annual age- and sex-standardized mortality rates were calculated for neoplasms, circulatory diseases, diabetes mellitus, and non-COVID communicable diseases
Rate differences and rate ratios contrasting MCOD with UCOD estimates were computed
Conclusions
MCOD surveillance methods reveal substantial underestimation of diabetes- and cardiovascular-related mortality, underscoring the value of MCOD surveillance for public health planning.
The authors conclude that reliance on UCOD alone misses a substantial portion of diabetes and CVD mortality burden
The underestimation was demonstrated in two distinct Latin American country contexts
The discrepancies were most pronounced during the COVID-19 pandemic years
The findings support incorporating MCOD methods into routine public health surveillance and planning
What This Means
This research suggests that official death statistics, which typically record only a single 'underlying cause' of death, may significantly undercount deaths related to diabetes and heart disease, particularly during the COVID-19 pandemic. By analyzing over 6 million death certificates from Brazil and over 1 million from Colombia between 2019 and 2022, the researchers compared the standard approach (counting only the primary cause of death) with a more comprehensive approach that also considers all contributing causes listed on the death certificate. They found that diabetes-related deaths were undercounted by as much as 70%, and cardiovascular disease deaths in Colombia were also substantially undercounted during 2020 and 2021, amounting to roughly 3,500 additional CVD deaths in 2021 alone that the standard method missed.
The study found that these gaps were much smaller and more stable for cancer deaths and deaths from other infectious diseases, suggesting that COVID-19 specifically made it harder to accurately attribute deaths involving diabetes and heart disease using the standard single-cause approach. When someone with diabetes or heart disease dies with COVID-19, the pandemic disease may be listed as the primary cause, making the chronic disease invisible in standard statistics.
This research suggests that public health agencies and policymakers should consider adopting multiple-cause-of-death analysis as a routine surveillance tool, especially during health emergencies like pandemics. Undercounting deaths from chronic diseases like diabetes and cardiovascular disease can lead to misallocation of healthcare resources and incomplete understanding of how pandemics affect people with pre-existing conditions in Latin America and potentially other regions.
Durán D, Carabali M, Bilal U, Nicolau B, Kaufman J. (2026). Multiple cause of death during the COVID-19 pandemic: a population study In Colombia and Brazil.. International journal of public health. https://doi.org/10.3389/ijph.2026.1609429